BERLIN--(BUSINESS WIRE)--Booster Therapeutics, a biotechnology company pioneering a new class of proteasome activator medicines to treat neurodegenerative and other diseases, launched today with ...

In this vein, a research team from Korea set out to investigate the relationship between two essential protein quality ...

Prokaryotic proteasomes are a rare breed: only the Archaea and a few members of the Actinomycetes have been shown to possess a proteasome. But now, this exclusive club has a new member — two ...

T he typical job of the proteasome, the garbage disposal of the cell, is to grind down proteins into smaller bits and recycle ...